AI Article Synopsis

  • Asbestos exposure is linked to the development of mesothelioma and reduces the immune system's ability to produce cytotoxic T lymphocytes (CTLs), crucial for fighting tumors.
  • In experiments, adding interleukin-15 (IL-15) to cultured immune cells exposed to asbestos partly restored the number of active CD8 T cells and increased granzyme B, a protein important for tumor cell destruction.
  • However, IL-15 did not reverse all the negative effects of asbestos, particularly regarding certain markers (CD25 and CD45RO) in CD8 lymphocytes, indicating a complex interaction between asbestos exposure and immune response.

Article Abstract

Background: Asbestos fibers possess tumorigenicity and are thought to cause mesothelioma. We have previously reported that exposure to asbestos fibers causes a reduction in antitumor immunity. Asbestos exposure in the mixed lymphocyte reaction (MLR) showed suppressed induction of cytotoxic T lymphocytes (CTLs), accompanied by a decrease in proliferation of CD8 T cells. Recently, we reported that asbestos-induced suppression of CTL induction is not due to insufficient levels of interleukin-2 (IL-2). In this study, we continue to investigate the mechanism responsible for the effect of asbestos fibers on the differentiation of CTLs and focus on interleukin-15 (IL-15) which is known to be a regulator of T lymphocyte proliferation.

Methods: For MLR, human peripheral blood mononuclear cells (PBMCs) were cultured with irradiated allogenic PBMCs upon exposure to chrysotile B asbestos at 5 μg/ml for 7 days. After 2 days of culture, IL-15 was added at 1 ng/ml. After 7 days of MLR, PBMCs were collected and analyzed for phenotypic and functional markers of CD8 T cells with fluorescence-labeled anti-CD3, anti-CD8, anti-CD45RA, anti-CD45RO, anti-CD25, and anti-granzyme B antibodies using flow cytometry. To examine the effect of IL-15 on the expression level of intracellular granzyme B in proliferating and non-proliferating CD8 lymphocytes, PBMCs were stained using carboxyfluorescein diacetate succinimidyl ester (CFSE) and then washed and used for the MLR.

Results: IL-15 addition partially reversed the decrease in CD3CD8 cell numbers and facilitated complete recovery of granzyme B cell percentages. IL-15 completely reversed the asbestos-induced decrease in percentage of granzyme B cells in both non-proliferating CFSE-positive and proliferating CFSE-negative CD8 cells. The asbestos-induced decrease in the percentage of CD25 and CD45RO cells in CD8 lymphocytes was not reversed by IL-15.

Conclusion: These findings indicate that CTLs induced upon exposure to asbestos possess dysfunctional machinery that can be partly compensated by IL-15 supplementation, and that IL-15 is more effective in the recovery of proliferation and granzyme B levels from asbestos-induced suppression of CTL induction compared with IL-2.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056682PMC
http://dx.doi.org/10.1186/s12199-021-00967-9DOI Listing

Publication Analysis

Top Keywords

asbestos-induced suppression
12
asbestos fibers
12
cd8 cells
12
il-15
8
il-15 addition
8
exposure asbestos
8
suppression ctl
8
ctl induction
8
cd8 lymphocytes
8
asbestos-induced decrease
8

Similar Publications

Pleural mesothelioma (PM) is a highly aggressive, fast-growing asbestos-induced cancer with limited effective treatments. There has been interest in using naturally occurring anticancer agents derived from plant materials for the treatment of PM. However, it is unclear if an aqueous extract from (QV0) has activity against PM.

View Article and Find Full Text PDF
Article Synopsis
  • Asbestos exposure is linked to the development of mesothelioma and reduces the immune system's ability to produce cytotoxic T lymphocytes (CTLs), crucial for fighting tumors.
  • In experiments, adding interleukin-15 (IL-15) to cultured immune cells exposed to asbestos partly restored the number of active CD8 T cells and increased granzyme B, a protein important for tumor cell destruction.
  • However, IL-15 did not reverse all the negative effects of asbestos, particularly regarding certain markers (CD25 and CD45RO) in CD8 lymphocytes, indicating a complex interaction between asbestos exposure and immune response.
View Article and Find Full Text PDF

The effects of asbestos on immunocompetent cells have been investigated. In particular, attention was paid to regulatory T cell function, which was observed using the HTLV-1 immortalized human polyclonal T cell line MT-2. Exposure to asbestos (approximately more than 25 μg/mL for 1-3 day) induced apoptosis, and we observed an increase in regulatory T cell function and acceleration of the cell cycle with continuous exposure to low concentrations of asbestos (5-10 μg/mL for more than eight months).

View Article and Find Full Text PDF

Malignant mesothelioma (MM) is an almost invariably fatal cancer caused by asbestos exposure. The toxicity of asbestos fibers is related to their physicochemical properties and the generation of free radicals. We set up a pilot study to investigate the potential of the zeolite clinoptilolite to counteract the asbestos carcinogenesis by preventing the generation of reactive nitrogen and oxygen radicals.

View Article and Find Full Text PDF

MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.

J Toxicol Environ Health A

February 2020

Department of Biomedical Informatics, School of Medicine, Pusan National University, Yangsan, Republic of Korea.

Malignant pleural mesothelioma (MPM) is a type of cancer characterized by a short survival time and poor prognosis. Malignant pleural mesothelioma is most frequently associated with exposure to asbestos and other elongated mineral fibers. The aim of this study was to examine molecular differences between asbestos-exposed and non-exposed MPM patients and assess prognostic significances of molecular factors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!